• DDM: From Membrane Solubilization to Drug Discovery

  2026-08-29

  Membrane proteins are difficult not because they lack biological importance, but because purification can disrupt the very lipid-dependent states researchers need to measure. This thought-leadership article explains how n-Dodecyl-β-D-maltoside, or DDM, can support a disciplined WecA workflow while clarifying its limits, assay controls, and translational value for anti-tuberculosis discovery.

• Sulforaphane: From Redox Signal to Assay Design

  2026-08-28

  Sulforaphane research is moving from single-endpoint measurements toward causal, multi-readout assay design. This guide connects Keap1–Nrf2 signaling with NLRP3 regulation, cell-cycle control, and practical workflows for cancer chemoprevention and oxidative stress response studies.

• A 83-01 ALK-5 Inhibitor Workflow

  2026-08-28

  Build cleaner TGF-β experiments with A 83-01, from receptor-level pathway inhibition to fibrosis, EMT, and organoid assays. This practical guide combines concentration planning, orthogonal readouts, and troubleshooting for more reproducible Smad-dependent transcription suppression.

• Tetraethylammonium Chloride: A Mechanistic Guide

  2026-08-27

  Tetraethylammonium chloride (TEAC) is more than a conventional potassium-channel blocker: it is a mechanistic perturbation tool for separating ion-conduction effects from receptor and tissue-level responses. This guide connects pore blockade, orthogonal assay design, β-cell physiology, vascular research, and practical product handling.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-08-27

  The Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003) helps researchers distinguish viable, early apoptotic, and membrane-compromised cells using phosphatidylserine binding and PI exclusion. It is intended for research workflows using flow cytometry or fluorescence microscopy, not clinical diagnosis, treatment decisions, or regulatory testing.

• L-Glutathione Reduced in Redox Assay Design

  2026-08-26

  L-Glutathione Reduced connects thiol redox chemistry with practical cancer-metabolism assay design. This evidence-based guide explains how to use reduced glutathione as a controlled reagent, interpret oxidative stress biomarker data, and complement GOT1-focused experiments without overclaiming mechanism.

• Luminescent ATP Cell Viability Assay Kit I Workflow

  2026-08-26

  Turn ATP-dependent luminescence into a rapid, high-sensitivity cell viability measurement for proliferation, drug combination, and ferroptosis studies. This workflow shows how to use the Luminescent ATP Cell Viability Assay Kit I to quantify CFX–RSL3 responses while avoiding common interpretation and plate-performance errors.

• Tigecycline Workflows for MDR Bacteria Research

  2026-08-25

  Tigecycline provides a practical phenotypic comparator for multidrug-resistant bacterial research, from broth microdilution to genotype-linked transmission studies. This workflow-oriented guide connects its 30S-targeted activity with CREC plasmid surveillance, MRSA research, troubleshooting, and translational assay design.

• Tigecycline Workflows for MDR Research

  2026-08-25

  Tigecycline provides a practical glycylcycline antibiotic framework for studying resistant pathogens, ribosome-targeted inhibition, and phenotypic susceptibility. This guide translates recent CREC transmission findings into reproducible assay workflows, comparator strategies, and troubleshooting decisions for MRSA, GISA, and multidrug-resistant bacteria research.

• Tetraethylammonium chloride in Cell Assays

  2026-08-24

  This scenario-based guide explains how Tetraethylammonium chloride, SKU B7262, can strengthen mechanistic interpretation in cell viability, proliferation, and cytotoxicity workflows without being mistaken for a generic viability reagent. It connects K+ channel blockade, solvent handling, orthogonal readouts, and supplier-quality checks to practical laboratory decisions.

• Ceapin-A7 and the Next Phase of ER Stress Research

  2026-08-24

  Ceapin-A7 provides a selective way to interrogate ATF6α signaling alongside the PERK–JAK1–STAT3 axis implicated in nucleus pulposus cell pyroptosis. This thought-leadership analysis connects pathway-selective pharmacology with translational study design for intervertebral disc degeneration and broader endoplasmic reticulum stress research.

• AP20187 Workflows for Controlled Dimerization

  2026-08-23

  AP20187 gives researchers temporal control over engineered signaling proteins, enabling conditional gene expression, regulated cell therapy, and metabolic assays. This guide connects practical dimerizer workflows with a chronic intermittent hypoxia pain model while clearly separating validated findings from assay-development opportunities.

• HyperScript™ Reverse Transcriptase for RNA Workflows

  2026-08-22

  Learn how HyperScript™ Reverse Transcriptase supports cDNA synthesis for qPCR when RNA is scarce, structured, or difficult to copy. This workflow-focused guide connects the enzyme’s thermal stability and reduced RNase H activity to transcriptomic validation in RPE/choroid and other demanding assays.

• FAST Food-Grade Nutraceutical Nanoparticles: Study Analysis

  2026-08-22

  This study evaluates Facilitated Self-Assembling Technology as a surfactant-free, food-grade route for producing stable nanoparticles from poorly soluble nutraceuticals. Its strongest evidence concerns particle formation, colloidal stability, simulated gastric behavior, and in-vitro compatibility, while direct enhancement of oral bioavailability remains to be demonstrated.

• Belinostat (PXD101): HDAC Research Guide

  2026-08-21

  Belinostat, also called PXD101, is a hydroxamate-type pan-HDAC inhibitor for preclinical epigenetic cancer research. Product data report nanomolar HDAC activity, histone H3/H4 acetylation, tumor-cell growth inhibition, and a bladder-tumor benchmark in mice, while these findings do not establish clinical efficacy.

8662 records 2/578 page Previous Next 12345 下5页 Last page